AS ONE Corporation Stock

Equities

7476

JP3131300000

Medical Equipment, Supplies & Distribution

Delayed Japan Exchange 02:00:00 2024-05-29 am EDT 5-day change 1st Jan Change
2,340 JPY -2.80% Intraday chart for AS ONE Corporation -3.98% -16.43%
Sales 2024 95.54B 608M Sales 2025 * 103B 655M Capitalization 172B 1.1B
Net income 2024 7.5B 47.73M Net income 2025 * 8.5B 54.11M EV / Sales 2024 1.99 x
Net cash position 2024 * 12.49B 79.47M Net cash position 2025 * 15.32B 97.47M EV / Sales 2025 * 1.53 x
P/E ratio 2024
25.6 x
P/E ratio 2025 *
20.7 x
Employees 668
Yield 2024
2.11%
Yield 2025 *
2.36%
Free-Float 74.43%
More Fundamentals * Assessed data
Dynamic Chart
AS ONE Corporation Provides Consolidated and Non-Consolidated Earnings Guidance for the Six Months Ending September 30, 2024 and Full Year Ending March 31, 2025 CI
AS ONE Corporation Declares Dividend for the Year Ended March 31, 2024, Payable on June 5, 2024 and Provides Dividend Guidance for the Year Ending March 31, 2025 CI
AS ONE Corporation Provides Dividend Guidance for the Second Quarter End of Year Ending March 31, 2024 CI
As One's Net Sales Up More Than 7% in February MT
Tranche Update on AS ONE Corporation's Equity Buyback Plan announced on March 12, 2024. CI
AS ONE Corporation's Equity Buyback announced on March 12, 2024, has closed with 400,000 shares, representing 1.1% for ¥2,076.4 million. CI
AS ONE Corporation Reports Sales Results for the Month of February 2024 CI
AS ONE Corporation announces an Equity Buyback for 440,000 shares, representing 1.22% for ¥2,284.04 million. CI
AS ONE Corporation authorizes a Buyback Plan. CI
AS ONE Corporation Reports Sales Results for the Month of January 2024 CI
AS ONE Corporation Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2024 CI
AS ONE Corporation Provides Year End Dividend Guidance for the Year Ending March 31, 2024 CI
AS ONE Corporation Reports Sales Results for the Month of December 2023 CI
As One's Net Sales Up 6% in November MT
AS ONE Corporation Reports Sales Results for the Month of November 2023 CI
More news
1 day-2.80%
1 week-3.98%
Current month-10.43%
1 month-10.43%
3 months-10.31%
6 months-8.16%
Current year-16.43%
More quotes
1 week
2 305.00
Extreme 2305
2 452.00
1 month
2 305.00
Extreme 2305
2 678.50
Current year
2 305.00
Extreme 2305
2 834.50
1 year
2 274.00
Extreme 2274
3 017.50
3 years
2 274.00
Extreme 2274
4 560.00
5 years
1 677.50
Extreme 1677.5
4 560.00
10 years
738.25
Extreme 738.25
4 560.00
More quotes
Managers TitleAgeSince
President 55 94-02-28
Director/Board Member 49 00-03-31
Director/Board Member 61 18-04-30
Members of the board TitleAgeSince
President 55 94-02-28
Director/Board Member 61 16-05-31
Director/Board Member 68 20-05-31
More insiders
Date Price Change Volume
24-05-29 2,340 -2.80% 102 900
24-05-28 2,408 -0.76% 114,300
24-05-27 2,426 +2.28% 132,200
24-05-24 2,372 +0.62% 114,000
24-05-23 2,358 -3.26% 131,600

Delayed Quote Japan Exchange, May 29, 2024 at 02:00 am EDT

More quotes
As One Corp is a Japan-based company principally engaged in the sale of scientific equipment and apparatus for various laboratories, research institutes, production facilities and medical facilities. The research and industrial equipment business is engaged in the wholesale of equipment and apparatus, which is used by researchers and technicians, to scientific equipment dealers. This business is also engaged in the provision of product catalogs to dealers, as well as the import and sale of physics and chemistry equipment. The hospital and nursing care business is engaged in the wholesale of equipment and apparatus, which is used by nursing care-related persons, to medical and nursing care institutions. The other business provides purchasing business proxy service using a web system, and to receive the system usage fee by the final user who participates in the system.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2,408 JPY
Average target price
3,500 JPY
Spread / Average Target
+45.38%
Consensus